Table of Contents
Cholesterol
Volume 2015, Article ID 706970, 6 pages
http://dx.doi.org/10.1155/2015/706970
Review Article

Optimal Use of Plant Stanol Ester in the Management of Hypercholesterolemia

1Raisio Group, Benecol Unit, P.O. Box 101, FI-21201 Raisio, Finland
2University of Helsinki and Helsinki University Hospital, Internal Medicine, P.O. Box 700, 00029 Helsinki, Finland

Received 1 July 2015; Accepted 27 September 2015

Academic Editor: Gloria L. Vega

Copyright © 2015 Susanna Rosin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization (WHO) and Cardiovascular Diseases (CVDs), “WHO Fact Sheet, no. 317,” 2015, http://www.who.int/mediacentre/factsheets/fs317/en/index.html.
  2. L. T. Clark, “Cholesterol and heart disease: current concepts in pathogenesis and treatment,” Journal of the National Medical Association, vol. 78, no. 8, pp. 743–751, 1986. View at Google Scholar · View at Scopus
  3. J. C. LaRosa, “Low-density lipoprotein cholesterol reduction: the end is more important than the means,” American Journal of Cardiology, vol. 100, no. 2, pp. 240–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. B. A. Ference, W. Yoo, I. Alesh, and et al, “Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease,” Journal of the American College of Cardiology, vol. 61, no. 18, pp. 1931–1932, 2013. View at Google Scholar · View at Scopus
  5. C. P. Cannon, “IMPROVE-IT trial: a comparison of ezetimibe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes after acute coronary syndromes,” Circulation, vol. 130, no. 23, p. 2109, 2014. View at Google Scholar
  6. M. R. Law, N. J. Wald, and S. G. Thompson, “By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?” British Medical Journal, vol. 308, no. 6925, pp. 367–372, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Catapano, Ž. Reiner, G. De Backer et al., “ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS),” Atherosclerosis, vol. 217, supplement 1, pp. S1–S44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Perk, G. De Backer, H. Gohlke et al., “European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts),” European Heart Journal, vol. 33, no. 13, pp. 1635–1701, 2012. View at Publisher · View at Google Scholar
  9. IAS International Atherosclerosis Society, “An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia,” 2013, http://www.athero.org/download/IASPPGuidelines_FullReport_20131011.pdf.
  10. M. R. DiMatteo, “Patient adherence to pharmacotherapy: the importance of effective communication,” Formulary, vol. 30, no. 10, pp. 596–601, 1995. View at Google Scholar · View at Scopus
  11. V. Piironen, D. G. Lindsay, T. A. Miettinen, J. Toivo, and A.-M. Lampi, “Plant sterols: biosynthesis, biological function and their importance to human nutrition,” Journal of the Science of Food and Agriculture, vol. 80, no. 7, pp. 939–966, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Phillips, M. T. Tarragó-Trani, and K. K. Stewart, “Phytosterol content of experimental diets differing in fatty acid composition,” Food Chemistry, vol. 64, no. 3, pp. 415–422, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. L. M. Valsta, A. Lemström, M.-L. Ovaskainen et al., “Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake,” British Journal of Nutrition, vol. 92, no. 4, pp. 671–678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Gylling, J. Plat, S. Turley et al., “Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease,” Atherosclerosis, vol. 232, no. 2, pp. 346–360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Lütjohann, C. O. Meese, J. R. Crouse III, and K. von Bergmann, “Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans,” Journal of Lipid Research, vol. 34, no. 6, pp. 1039–1046, 1993. View at Google Scholar · View at Scopus
  16. H. Gylling, R. Radhakrishnan, and T. A. Miettinen, “Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol,” Circulation, vol. 96, no. 12, pp. 4226–4231, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Gylling and T. A. Miettinen, “Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men,” The Journal of Lipid Research, vol. 37, no. 8, pp. 1776–1785, 1996. View at Google Scholar · View at Scopus
  18. T. T. Nguyen, L. C. Dale, K. von Bergmann, and I. T. Croghan, “Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial,” Mayo Clinic Proceedings, vol. 74, no. 12, pp. 1198–1206, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. N. B. Cater, “Plant stanol ester: review of cholesterol-lowering efficacy and implications for coronary heart disease risk reduction,” Preventive Cardiology, vol. 3, no. 3, pp. 121–130, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. E. A. Trautwein, G. S. M. J. E. Duchateau, Y. Lin, S. M. Mel'nikov, H. O. F. Molhuizen, and F. Y. Ntanios, “Proposed mechanisms of cholesterol-lowering action of plant sterols,” European Journal of Lipid Science and Technology, vol. 105, no. 3-4, pp. 171–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Plat and R. P. Mensink, “Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects,” The American Journal of Cardiology, vol. 96, no. 1, pp. 15D–22D, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Scientific Opinion of the Panel on Dietetic Products-Nutrition and Allergies, “Plant stanol esters and blood cholesterol. Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/20061,” EFSA Journal, vol. 825, pp. 1–13, 2008. View at Google Scholar
  23. K. Musa-Veloso, T. H. Poon, J. A. Elliot, and C. Chung, “A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 85, no. 1, pp. 9–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. T. A. Miettinen, P. Puska, H. Gylling, H. Vanhanen, and E. Vartiainen, “Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population,” The New England Journal of Medicine, vol. 333, no. 20, pp. 1308–1312, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. M. B. Katan, S. M. Grundy, P. Jones, M. Law, T. Miettinen, and R. Paoletti, “Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels,” Mayo Clinic Proceedings, vol. 78, no. 8, pp. 965–978, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. V. G. Athyros, A. I. Kakafika, A. A. Papageorgiou et al., “Effect of a plant stanol ester-containing spread, placebo spread, or mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 3, pp. 213–221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Scientific Opinion of the Panel on Dietetic Products, Nutrition, and Allergies, “Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006,” The EFSA Journal, vol. 10, no. 5, article 2692, 15 pages, 2012. View at Google Scholar
  28. R. P. Mensink, S. Ebbing, M. Lindhout, J. Plat, and M. M. A. van Heugten, “Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations,” Atherosclerosis, vol. 160, no. 1, pp. 205–213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Noakes, P. M. Clifton, A. M. E. Doornbos, and E. A. Trautwein, “Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects,” European Journal of Nutrition, vol. 44, no. 4, pp. 214–222, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Hallikainen, E. Sarkkinen, I. Wester, and M. Uusitupa, “Short-term LDL cholesterol-lowering efficacy of plant stanol esters,” BMC Cardiovascular Disorders, vol. 2, article 14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. P. J. Jones, M. Raeini-Sarjaz, F. Y. Ntanios, C. A. Vanstone, J. Y. Feng, and W. E. Parsons, “Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters,” The Journal of Lipid Research, vol. 41, no. 5, pp. 697–705, 2000. View at Google Scholar · View at Scopus
  32. I. Parraga-Martinez, J. D. Lopez-Torres-Hidalgo, J. M. Del Campo-Del Campo, and et al, “Long-term effects of plant stanols on the lipid profile of patients with hypercholesterolemia. A randomized clinical trial,” Revista Española de Cardiología, vol. 68, no. 8, pp. 665–671, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. A. de Jong, J. Plat, A. Bast, R. W. L. Godschalk, S. Basu, and R. P. Mensink, “Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment,” European Journal of Clinical Nutrition, vol. 62, no. 2, pp. 263–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. National Cholesterol Education Program, National Heart-Lung and Blood Institute, and National Institutes of Health, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, NIH Publication no. 02-5215, National Cholesterol Education Program, 2002.
  35. S. N. Blair, D. M. Capuzzi, S. O. Gottlieb, T. Nguyen, J. M. Morgan, and N. B. Cater, “Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy,” American Journal of Cardiology, vol. 86, no. 1, pp. 46–52, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Homma, I. Ikeda, T. Ishikawa, M. Tateno, M. Sugano, and H. Nakamura, “Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial,” Nutrition, vol. 19, no. 4, pp. 369–374, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Hallikainen and M. I. J. Uusitupa, “Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects,” The American Journal of Clinical Nutrition, vol. 69, no. 3, pp. 403–410, 1999. View at Google Scholar · View at Scopus
  38. J. Plat, D. Mackay, S. Baumgartner et al., “Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting,” Atherosclerosis, vol. 225, no. 2, pp. 521–533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. WHO food additives series, 60, Safety evaluation of certain food additives/prepared by the sixty-ninth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) http://whqlibdoc.who.int/publications/2009/9789241660600_eng.pdf.
  40. L. Soupas, L. Huikko, A.-M. Lampi, and V. Piironen, “Pan-frying may induce phytosterol oxidation,” Food Chemistry, vol. 101, no. 1, pp. 286–297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. US FDA GRAS Notice no. GRN 000438, Plant stanol esters, 2013, http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm338918.htm.
  42. R. P. Mensink, A. de Jong, D. Lütjohann, G. R. M. M. Haenen, and J. Plat, “Plant stanols dose-dependently decrease LDL-cholesterol concentrations, but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d,” American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 24–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Gylling, M. Hallikainen, M. J. Nissinen, and T. A. Miettinen, “The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins,” Clinical Nutrition, vol. 29, no. 1, pp. 112–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Marttinen, M. Kosola, M.-L. Ovaskainen, M. Mutanen, and S. Männistö, “Plant sterol and stanol intake in Finland: a comparison between users and nonusers of plant sterol- and plant stanol-enriched foods,” European Journal of Clinical Nutrition, vol. 68, no. 5, pp. 587–591, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. I. Willems, M. A. E. Blommaert, and E. A. Trautwein, “Results from a post-launch monitoring survey on consumer purchases of foods with added phytosterols in five European countries,” Food and Chemical Toxicology, vol. 62, pp. 48–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Musa-Veloso and T. H. Poon, “Rebuttal to comment from Demonty et al. (2011),” Prostaglandins, Leukotrienes & Essential Fatty Acids, vol. 85, no. 3-4, pp. 189–193, 2011. View at Publisher · View at Google Scholar
  47. Scientific Opinion of the Panel on Dietetic Products, Nutrition, and Allergies, “Plant Stanols and Plant Sterols and Blood LDL-Cholesterol Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from the European Commission and a similar request from France in relation to the authorization procedure for health claims on plant stanols and plant sterols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006,” The EFSA Journal, vol. 1175, pp. 1–9, 2009. View at Google Scholar
  48. J. Plat, E. N. M. van Onselen, M. M. A. van Heugten, and R. P. Mensink, “Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters,” European Journal of Clinical Nutrition, vol. 54, no. 9, pp. 671–677, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Kriengsinyos, A. Wangtong, and S. Komindr, “Serum cholesterol reduction efficacy of biscuits with added plant stanol ester,” Cholesterol, vol. 2015, Article ID 353164, 9 pages, 2015. View at Publisher · View at Google Scholar
  50. A. M. E. Doornbos, E. M. Meynen, G. S. M. J. E. Duchateau, H. C. M. van der Knaap, and E. A. Trautwein, “Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects,” European Journal of Clinical Nutrition, vol. 60, no. 3, pp. 325–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Nissinen, H. Gylling, M. Vuoristo, and T. A. Miettinen, “Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 282, no. 6, pp. G1009–G1015, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. M. A. Hallikainen, E. S. Sarkkinen, H. Gylling, A. T. Erkkilä, and M. I. J. Uusitupa, “Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet,” European Journal of Clinical Nutrition, vol. 54, no. 9, pp. 715–725, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Andersson, B. Karlstrom, R. Mohsen, and B. Vessby, “Cholesterol-lowering effects of a stanol ester-containing low-fat margarine used in conjunction with a strict lipid-lowering diet,” European Heart Journal, Supplement, vol. 1, pp. S80–S90, 1999. View at Google Scholar · View at Scopus
  54. M. Castro Cabezas, J. H. M. de Vries, A. J. H. H. M. Van Oostrom, J. Iestra, and W. A. van Staveren, “Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins,” Journal of the American Dietetic Association, vol. 106, no. 10, pp. 1564–1569, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. N. B. Cater, A.-B. Garcia-Garcia, G. L. Vega, and S. M. Grundy, “Responsiveness of plasma lipids and lipoproteins to plant stanol esters,” American Journal of Cardiology, vol. 96, no. 1, pp. 23D–28D, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. de Jong, J. Plat, D. Lütjohann, and R. P. Mensink, “Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment,” British Journal of Nutrition, vol. 100, no. 5, pp. 937–941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Hallikainen, S. Kurl, M. Laakso, T. A. Miettinen, and H. Gylling, “Plant stanol esters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol,” Atherosclerosis, vol. 217, no. 2, pp. 473–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Vanhanen, “Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients,” European Journal of Clinical Pharmacology, vol. 47, no. 2, pp. 169–176, 1994. View at Google Scholar · View at Scopus
  59. J. M. Scholle, W. L. Baker, R. Talati, and C. I. Coleman, “The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis,” Journal of the American College of Nutrition, vol. 28, no. 5, pp. 517–524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. A. B. Evert, J. L. Boucher, M. Cypress et al., “Nutrition therapy recommendations for the management of adults with diabetes,” Diabetes Care, vol. 37, supplement 1, pp. S120–S143, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. de Jesus, “Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report,” Pediatrics, vol. 128, supplement 5, pp. S213–S256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. B. G. Nordestgaard, M. J. Chapman, S. E. Humphries et al., “Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease,” European Heart Journal, vol. 34, no. 45, pp. 3478–3490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Hovingh, P. T. Kovanen, C. Boileau et al., “EAS Consensus Paper. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease,” European Heart Journal, vol. 34, no. 45, pp. 3478–3490, 2013. View at Publisher · View at Google Scholar
  64. E. S. Stroes, P. D. Thompson, A. Corsini et al., “Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management,” European Heart Journal, vol. 36, no. 17, pp. 1012–1022, 2015. View at Publisher · View at Google Scholar